Portopulmonary hypertension and Paranasal sinus hypersecretion
Paranasal sinus hypersecretion is reported only by a few people with Portopulmonary hypertension.
The study analyzes which people have Paranasal sinus hypersecretion with Portopulmonary hypertension. It is created by eHealthMe based on 1 person who has Paranasal sinus hypersecretion and Portopulmonary hypertension from the Food and Drug Administration (FDA), and is updated regularly.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
1 person who has Portopulmonary Hypertension and Paranasal Sinus Hypersecretion is studied.
What is Portopulmonary hypertension?
Portopulmonary hypertension (coexistence of portal and pulmonary hypertension) is found to be associated with 72 drugs and 23 conditions by eHealthMe.
What is Paranasal sinus hypersecretion?
Paranasal sinus hypersecretion is found to be associated with 729 drugs and 393 conditions by eHealthMe.
Number of Paranasal sinus hypersecretion in Portopulmonary hypertension reports submitted per year:
Gender of people who have Portopulmonary Hypertension and experienced Paranasal Sinus Hypersecretion *:
- female: 0.0 %
- male: 100 %
Common co-existing conditions for these people *:
- Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 1 person, 100.00%
Common drugs taken by these people *:
- Tyvaso: 1 person, 100.00%
- Letairis: 1 person, 100.00%
- Adcirca: 1 person, 100.00%
Common symptoms for these people *:
- Urinary Tract Infection: 1 person, 100.00%
- Upper Respiratory Tract Infection: 1 person, 100.00%
- Renal Failure Acute (rapid kidney dysfunction): 1 person, 100.00%
- Local Swelling (swelling at the site of some application of substance or injury): 1 person, 100.00%
- Gout (uric acid crystals building up in the body): 1 person, 100.00%
* Approximation only. Some reports may have incomplete information.
Do you take medications and have Paranasal sinus hypersecretion?Check whether Paranasal sinus hypersecretion is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Treatments, associated drugs and conditions:
COVID vaccines that are related to Paranasal sinus hypersecretion:
- Paranasal sinus hypersecretion in Moderna COVID Vaccine
- Paranasal sinus hypersecretion in Pfizer BioNTech Covid Vaccine
- Paranasal sinus hypersecretion in Johnson and Johnson Covid Vaccine
Common drugs associated with Paranasal sinus hypersecretion:
All the drugs that are associated with Paranasal sinus hypersecretion:
- Paranasal sinus hypersecretion (729 drugs)
Common conditions associated with Paranasal sinus hypersecretion:
All the conditions that are associated with Paranasal sinus hypersecretion:
- Paranasal sinus hypersecretion (393 conditions)
How the study uses the data?
The study is based on Paranasal sinus hypersecretion and Portopulmonary hypertension, and their synonyms.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Amphetamines Positive and drugs of ingredients of cyclobenzaprine hydrochloride - now
- Namenda and Speech Impairment (Adult) - a second ago
- Prevpac and Fatigue - 5 seconds ago
- Aredia and Aortic Valve Incompetence - 24 seconds ago
- Dovonex and Hyponatremia - 25 seconds ago
- Oseltamivir Phosphate and Anhedonia - 28 seconds ago
- Alcoholic Liver Disease and Hepatic Function Abnormal - 31 seconds ago
- Avastin and Blood Bilirubin Increased - 35 seconds ago
- Cyclophosphamide and Radiation Skin Injury - 41 seconds ago
- Serzone and Hypoglycemia - 53 seconds ago